Literature DB >> 10980929

Variant forms of autoimmune hepatitis.

A J Czaja1.   

Abstract

Variant forms of autoimmune hepatitis have features that are intermixed with another disorder (overlap syndrome) or findings that are inconsistent with or insufficient for a confident diagnosis of classic disease (outlier syndrome). Diagnostic criteria have not been codified, but application of a modified scoring system provides a template that can be combined with clinical findings to ensure uniform evaluation and classification. Variant forms are frequently assimilated into conventional diagnostic categories. and they may distort analyses of natural history and outcome. Management strategies are empiric, based on an assessment of the predominant characteristics and institution of the most appropriate drug regimen. Patients with variant syndromes who respond to corticosteroids typically have serum alkaline phosphatase levels of less than twofold the upper limit of normal at presentation. By distinguishing between these syndromes, further insights into natural history, genetic predisposition, and immunopathic mechanisms are possible.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10980929     DOI: 10.1007/s11894-999-0089-0

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  36 in total

1.  Antibodies to carbonic anhydrase in autoimmune cholangiopathy.

Authors:  P Muratori; L Muratori; M Lenzi; F B Bianchi
Journal:  Gastroenterology       Date:  1997-03       Impact factor: 22.682

2.  Meeting report: International Autoimmune Hepatitis Group.

Authors:  P J Johnson; I G McFarlane
Journal:  Hepatology       Date:  1993-10       Impact factor: 17.425

3.  Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis.

Authors:  K Tsuneyama; J Van De Water; D Van Thiel; R Coppel; B Ruebner; Y Nakanuma; E R Dickson; M E Gershwin
Journal:  Hepatology       Date:  1995-11       Impact factor: 17.425

4.  Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis.

Authors:  P Michieletti; I R Wanless; A Katz; P J Scheuer; S J Yeaman; M F Bassendine; J M Palmer; E J Heathcote
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

5.  Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.

Authors:  A J Czaja; H A Carpenter; M P Manns
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

6.  Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis.

Authors:  A J Czaja; H A Carpenter
Journal:  Gastroenterology       Date:  1993-12       Impact factor: 22.682

7.  Significance of human leukocyte antigens DR3 and DR4 in chronic viral hepatitis.

Authors:  A J Czaja; H A Carpenter; P J Santrach; S B Moore
Journal:  Dig Dis Sci       Date:  1995-10       Impact factor: 3.199

8.  Validation of scoring system for diagnosis of autoimmune hepatitis.

Authors:  A Czaja; H A Carpenter
Journal:  Dig Dis Sci       Date:  1996-02       Impact factor: 3.199

9.  High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.

Authors:  B D Clifford; D Donahue; L Smith; E Cable; B Luttig; M Manns; H L Bonkovsky
Journal:  Hepatology       Date:  1995-03       Impact factor: 17.425

10.  The nature and prognosis of severe cryptogenic chronic active hepatitis.

Authors:  A J Czaja; H A Carpenter; P J Santrach; S B Moore; H A Homburger
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

View more
  14 in total

Review 1.  Autoimmune hepatitis and its variant syndromes.

Authors:  Z Ben-Ari; A J Czaja
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

2.  Diagnosing clinical subsets of autoimmune liver diseases based on a multivariable model.

Authors:  Mikio Zeniya; Fumitoki Watanabe; Toshio Morizane; Minoru Shibata; Shiro Maeyama; Masayoshi Kage; Yasuni Nakanuma; Gotaro Toda
Journal:  J Gastroenterol       Date:  2005-12       Impact factor: 7.527

Review 3.  Autoimmune hepatitis.

Authors:  Farhad Sahebjam; John M Vierling
Journal:  Front Med       Date:  2015-03-06       Impact factor: 4.592

4.  Performance parameters of the conventional serological markers for autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-12-03       Impact factor: 3.199

5.  Involvement of (IgG and IgM)-secreting B lymphocytes in severity of autoimmune hepatitis type 1.

Authors:  Ayaid Khadem Zgair
Journal:  Med Microbiol Immunol       Date:  2013-01-08       Impact factor: 3.402

Review 6.  Difficult treatment decisions in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

Review 7.  Diagnosis and management of the overlap syndromes of autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Can J Gastroenterol       Date:  2013-07       Impact factor: 3.522

Review 8.  The overlap syndromes of autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-08-24       Impact factor: 3.199

Review 9.  Update on autoimmune hepatitis.

Authors:  Andreas Teufel; Peter R Galle; Stephan Kanzler
Journal:  World J Gastroenterol       Date:  2009-03-07       Impact factor: 5.742

10.  Small-duct primary sclerosing cholangitis.

Authors:  Einar Björnsson
Journal:  Curr Gastroenterol Rep       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.